6533b825fe1ef96bd12828e1

RESEARCH PRODUCT

Towards personalized screening for hepatocellular carcinoma: Still not there

Vincenza CalvarusoJordi Bruix

subject

Oncologymedicine.medical_specialtyCarcinoma HepatocellularHepatologybusiness.industryLiver CirrhosiMEDLINEHepatitis Cmedicine.diseaseHepatitis CMachine LearningLiver Neoplasms.Text miningHepatocellular carcinomaInternal medicinemedicinebusinessHuman

description

In patients with HCV-related cirrhosis the annual risk of hepatocellular carcinoma (HCC) is 2–4%.1 However, with the advent of highly effective and well tolerated direct-acting antivirals...

https://doi.org/10.1016/j.jhep.2020.06.032